Annuaire
Vous êtes ici : Version française
Enseignant chercheur
M. Pierre Sierocki
Coordonnées
7ème Bat. Vialle
- Tél
- 0247366351
- pierre.sierocki@univ-tours.fr
- Site internet
- www.linkedin.com/in/pierre-sierocki-83636283
Discipline(s)
Sciences du médicament et des autres produits de santé
Discipline(s) enseignée(s)
Chimie Organique & Chimie Médicinale
Activités / CV
Fougiaxis, V.; Barcherini, V.; Petrovic, M. M.; Sierocki, P.; Warenghem, S.; Leroux, F.; Bou Karroum, N.; Petit-Cancelier, F.; Rodeschini, V.; Roche, D.; Deprez, B.; Deprez-Poulain, R. First Fragment-Based Screening Identifies New Chemotypes Inhibiting ERAP1-Metalloprotease. European Journal of Medicinal Chemistry 2024, 280, 116926. https://doi.org/10.1016/j.ejmech.2024.116926.
Fougiaxis, V.; He, B.; Khan, T.; Vatinel, R.; Koutroumpa, N. M.; Afantitis, A.; Lesire, L.; Sierocki, P.; Deprez, B.; Deprez-Poulain, R. ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights. J. Med. Chem. 2024. https://doi.org/10.1021/acs.jmedchem.4c00840.
Poulain, R. D.; Gealageas, R.; Camberlein, V.; Fleau, C. T.; Guillaume, V.; Bosc, D.; Deprez, B.; Sierocki, P. Erap Inhibitors. US2024101542 (A1).
Camberlein, V.; Fléau, C.; Sierocki, P.; Li, L.; Gealageas, R.; Bosc, D.; Guillaume, V.; Warenghem, S.; Leroux, F.; Rosell, M.; Cheng, K.; Medve, L.; Prigent, M.; Decanter, M.; Piveteau, C.; Biela, A.; Eveque, M.; Dumont, J.; Mpakali, A.; Giastas, P.; Herledan, A.; Couturier, C.; Haupenthal, J.; Lesire, L.; Hirsch, A. K. H.; Deprez, B.; Stratikos, E.; Bouvier, M.; Deprez-Poulain, R. Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target-Guided Synthesis. Angewandte Chemie International Edition 2022, 61 (39), e202203560. https://doi.org/10.1002/anie.202203560.
Sierocki, P.; Gaillard, K.; Reyes, R. A. A.; Donnart, C.; Lambert, E.; Grosse, S.; Arzel, L.; Tessier, A.; Guillemont, J.; Mathé-Allainmat, M.; Lebreton, J. Synthesis of Novel C-Nucleoside Analogues Bearing an Anomeric Cyano and a 1,2,3-Triazole Nucleobase as Potential Antiviral Agents. Org. Biomol. Chem. 2022, 20 (13), 2715–2728. https://doi.org/10.1039/D1OB02451E.
Aoun, S.; Sierocki, P.; Lebreton, J.; Mathé-Allainmat, M. Linear and Convergent Syntheses of Bifunctional Hydroxy-Bisphosphonic Compounds as Potential Bone-Targeting Prodrugs. Synthesis 2019, 51 (18), 3556–3566. https://doi.org/10.1055/s-0037-1611540.
Fougiaxis, V.; He, B.; Khan, T.; Vatinel, R.; Koutroumpa, N. M.; Afantitis, A.; Lesire, L.; Sierocki, P.; Deprez, B.; Deprez-Poulain, R. ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights. J. Med. Chem. 2024. https://doi.org/10.1021/acs.jmedchem.4c00840.
Poulain, R. D.; Gealageas, R.; Camberlein, V.; Fleau, C. T.; Guillaume, V.; Bosc, D.; Deprez, B.; Sierocki, P. Erap Inhibitors. US2024101542 (A1).
Camberlein, V.; Fléau, C.; Sierocki, P.; Li, L.; Gealageas, R.; Bosc, D.; Guillaume, V.; Warenghem, S.; Leroux, F.; Rosell, M.; Cheng, K.; Medve, L.; Prigent, M.; Decanter, M.; Piveteau, C.; Biela, A.; Eveque, M.; Dumont, J.; Mpakali, A.; Giastas, P.; Herledan, A.; Couturier, C.; Haupenthal, J.; Lesire, L.; Hirsch, A. K. H.; Deprez, B.; Stratikos, E.; Bouvier, M.; Deprez-Poulain, R. Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target-Guided Synthesis. Angewandte Chemie International Edition 2022, 61 (39), e202203560. https://doi.org/10.1002/anie.202203560.
Sierocki, P.; Gaillard, K.; Reyes, R. A. A.; Donnart, C.; Lambert, E.; Grosse, S.; Arzel, L.; Tessier, A.; Guillemont, J.; Mathé-Allainmat, M.; Lebreton, J. Synthesis of Novel C-Nucleoside Analogues Bearing an Anomeric Cyano and a 1,2,3-Triazole Nucleobase as Potential Antiviral Agents. Org. Biomol. Chem. 2022, 20 (13), 2715–2728. https://doi.org/10.1039/D1OB02451E.
Aoun, S.; Sierocki, P.; Lebreton, J.; Mathé-Allainmat, M. Linear and Convergent Syntheses of Bifunctional Hydroxy-Bisphosphonic Compounds as Potential Bone-Targeting Prodrugs. Synthesis 2019, 51 (18), 3556–3566. https://doi.org/10.1055/s-0037-1611540.